Autism spectrum disorder (ASD) is now estimated to impact one in every 68 children born in the United States. A new 5-year, $5.1 million grant from the National Institute of Mental Health (NIMH) seeks expand a program developed by researchers at University of California, San Diego School of Medicine to reduce the mean age of ASD diagnosis in multiple cities across the U.S.
Researchers at the University of California, San Diego School of Medicine, in partnership with ViaCyte, Inc., a San Diego-based biotechnology firm specializing in regenerative medicine, have launched the first-ever human Phase I/II clinical trial of a stem cell-derived therapy for patients with Type 1 diabetes.
Meanwhile, health care is increasingly moving toward the use of biometric devices – gadgets embedded with wireless sensors – to unobtrusively monitor patients’ health data in real time, from blood pressure and insulin levels to number of steps walked per day.
To help get the word out that alcohol and pregnancy don’t mix, volunteers with the Southern California affiliate of the National Organization on Fetal Alcohol Syndrome (SoCal NOFAS) are handing out “Pregnant? Don’t Drink” coasters to San Diego area bars and restaurants on Tuesday, September 9th as part of International Fetal Alcohol Spectrum Disorders (FASD) Awareness Day.
Researchers at the University of California, San Diego School of Medicine have identified an enzyme that controls the spread of breast cancer. The findings, reported in the current issue of PNAS, offer hope for the leading cause of breast cancer mortality worldwide.
The University of California, San Diego and the Universidad Autonoma de Baja California, Mexico (UABC) have embarked on an initiative to increase collaboration and exchange among students and faculty from both universities. The initiative was formalized by a Memorandum of Understanding (MOU) signed by UC San Diego Chancellor Pradeep K. Khosla and UABC President Felipe Cuamea Velazquez.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
